Eu Cpnp Cosmetics Notification Responsible Person Service

Scope and evidence must be confirmed before any paid tests or filings.

For a cosmetic product placed on the EU market, a natural or legal person established in the EU must be identifiable as its Responsible Person (RP). A CPNP account, consultant, freight agent or portal-submission receipt does not itself establish that legal role. The first decision is who bears the role under Article 4 of Regulation (EC) No 1223/2009—and whether a lawful written appointment is needed.

This page addresses EU cosmetics representation: selection of the RP, accepted mandate, records and authority contacts, continuing liability and transfer to another RP. It does not replace the product safety assessment or a product-specific CPNP filing.

Which operator is the Responsible Person? Route matrix

Apply the manufacturing, import and branding facts to each product and supply chain. “Default” means the legal starting point, not a label chosen by contract alone.

Identity test under Article 2: The “manufacturer” is the person who makes, or has made, a cosmetic and markets it under that person’s name or trademark; the physical factory alone does not determine the legal manufacturer. An “importer” is an EU-established person who first makes a cosmetic from a third country available on the EU market. Do not assign these roles from the shipping documents, warehouse address or CPNP login alone.

Situation	Article 4 starting position	Decision before engaging a service
EU-established manufacturer, product made in the EU	That manufacturer is the RP by default.	It may appoint a different EU-established RP by written mandate accepted in writing.
Non-EU manufacturer, product made inside the EU and not re-imported	The manufacturer must designate an EU-established RP.	Obtain the manufacturer’s mandate and the RP’s written acceptance before market placement.
Cosmetic imported from outside the EU	Each importer is RP for the specific product it places on the market.	Each relevant importer should assess whether to appoint a common EU RP under a written, accepted mandate; one brand-level assertion does not cover unknown importer arrangements.
Distributor sells under its name/trademark or changes product so compliance may be affected	Distributor becomes RP under Article 4(6).	Check the real branding/modification facts before assuming a service provider can simply replace this statutory role.
Distributor merely translates information for national-law compliance	Translation alone is not an Article 4(6) modification.	Assess the separate distributor CPNP duty under Article 13(3), where its conditions are met; do not mistake this for becoming RP.

Article 13(3) translation gate: When a distributor makes a cosmetic available in one Member State after it was already placed on the market in another, and on its own initiative translates any part of the label to comply with national law, the distributor must submit the separate Article 13(3) notification. Compare both Member States, original and translated labels, previous market placement and who initiated the translation; this is not an RP appointment.

Legal RP versus CPNP portal operator

The RP is the substantive compliance duty-holder under Articles 4–5. A consultant may prepare data, a delegated user may operate CPNP, and an importer or brand can supply records; these operational permissions do not automatically transfer the RP’s legal duties. Confirm whose identity will appear in the notification, on the label and at the PIF access address.

Regulation 1223/2009 does not impose a general “RP certificate” as a substitute for EU establishment and lawful appointment. The qualified safety assessor under Article 10(2) is a different role; an RP appointment does not qualify its holder to sign a cosmetic product safety assessment. The Commission provides CPNP without a portal filing fee; professional representation or preparation may have commercial charges.

Written appointment: six points to settle

Where Article 4 allows or requires designation, the mandate must be in writing and the EU-based candidate must accept in writing. The following contractual controls are risk-management measures rather than a prescribed EU mandate form:

Identify the appointing legal entity, the RP’s EU-established legal identity and the exact products/SKUs, brands and markets covered.
Record signed mandate and written acceptance, an effective handover date, and who coordinates importer-specific appointments.
Specify where the PIF can be readily accessed at the label address and who maintains secure access to formulas, CPSRs, tests and claims support.
Allocate information-supply duties, review/approval of labels and CPNP data, urgent incident contacts and regulator-response escalation.
Set change-notice triggers for formulation, manufacturer, packaging, claims, importer and RP address changes.
Specify termination and handover of files, records, portal administration and products already on shelves; private indemnities do not remove statutory RP duties.

Records the incoming RP must be able to verify

Ask for a product-indexed handoff, not a generic “CPNP certificate.” Deficiencies should be resolved before the RP accepts responsibility for launching an affected product.

Definitive formula/INCI and ingredient specifications, intended use, exposure profile, manufacturing sites and GMP statement.
A current Cosmetic Product Safety Report (CPSR) signed by a suitably qualified assessor and traceable to the marketed formula.
A Product Information File (PIF) with product description, safety report, manufacturing method/GMP, claim substantiation where appropriate and relevant animal-testing information.
Final packaging and readable labels showing the RP name/address, imported-product origin where applicable, warnings, batch identification and other required particulars.
CPNP record ownership/access, product names/categories, importing origin, contact person, frame formula and any relevant nanomaterial/CMR disclosures.
Launch countries, importer/distributor map, prior incidents, complaints, adverse-effect records and pending authority correspondence.

Operational responsibility split: RP cannot be a passive mailbox

Workstream	RP statutory accountability	Data or support typically supplied by others
Pre-launch safety	Ensure safety assessment and CPSR before placing on market (Art. 10).	Manufacturer, qualified assessor and laboratories provide underlying evidence.
PIF and label address	Maintain PIF and make it readily accessible at the label address; retain ten years after last batch is placed on market (Art. 11).	Brand/manufacturer keeps specs, manufacturing data and version records available.
Portal notification	Ensure RP notification before placement and updates without delay when notified details change (Art. 13).	Consultant or authorised portal user may perform data entry; RP remains the role-holder.
Market incidents	Take required corrective action, withdrawal/recall as appropriate; notify authorities immediately when product presents a risk; report serious undesirable effects without delay (Arts. 5, 23).	Brand, sellers and distributors route complaints, trace batches and support response.
Authority inspection	Cooperate and provide requested compliance evidence in a language easily understood by the competent authority (Art. 5).	Manufacturer and specialists assist with explanations and original records.

Three controls that determine whether representation works

One product, mapped importers: with two unrelated importers, do not assume a single notification or informal brand appointment determines every importer’s Article 4 position.
PIF at a real access point: verify the labelled RP address can make the current file readily accessible and respond to the authority, not merely forward post.
Change escalation: set a documented stop/review path before new formula, claims, relabelling or ownership changes; CPNP notification does not cure a non-compliant product.

Replacing an RP: continuity and stop/go checks

A change of service provider must be treated as a regulated product handover, not only a CPNP login change. Before release under a new RP, establish the lawful appointment route, file access, label identity and notification updates. Article 13(7) requires changes to notified information to be updated without delay; Article 19 requires the RP name/address on the label.

CPNP transfer gate: Verify with the outgoing and incoming RPs, using current portal instructions, whether an existing product notification can be transferred and updated or whether another appropriate notification route is required. Article 13(7) does not grant the new RP automatic access to the former RP’s account. Confirm the actual filing position alongside the mandate, label and PIF, rather than relying on an old CPNP screenshot.

Map products, each importer/brand and the incumbent RP; isolate stock bearing the old identity.
Obtain the new accepted written mandate where required and secure the complete version-controlled PIF/CPSR.
Check new label RP details and which existing stock may need relabelling or other corrective measures before further market activity.
Arrange appropriate CPNP identity/data updates and verify operational access; keep auditable submission records.
Agree ownership of historic complaints, authority letters, adverse-effect reporting and 10-year PIF retention; resolve gaps before go-live.

What appointing a cosmetics RP does not replace

CPNP is notification, not EU approval, a marketing licence or proof that a formula is safe. A valid RP does not remove the need for formula restrictions, labelling, GMP and the CPSR/PIF. Nanomaterials may require a separate Article 16 notification; certain distributor translations trigger Article 13(3) rather than a new RP appointment. These issues must be classified on facts, not assumed.

For strategic classification or dossier-gap decisions, use the EU CPNP cosmetics notification consultant page. For the mechanics and deliverables of the actual portal submission, use the EU CPNP cosmetics notification service page. The wider cross-product meaning of EU representation is addressed under EU responsible person services.

Questions specific to appointing a cosmetics RP

Can our non-EU brand notify the product itself and skip the EU RP?

No. A product placed on the EU market needs an EU-established RP under Article 4. Portal access or outsourced data entry is not a substitute. Identify whether a manufacturer or each importer must arrange the written appointment.

Does an EU importer automatically cease to be RP when our brand signs a global agency agreement?

Not necessarily. Article 4(5) makes each importer RP for the specific imported product unless that importer designates an EU-established person by written mandate accepted in writing. Audit the importer-specific arrangements.

Is a new RP mandatory when a reseller only translates the label?

Not for that reason alone: translation of information for an already marketed cosmetic is not itself an Article 4(6) modification. A distributor notification duty under Article 13(3) may still arise if its specific conditions are met.

Can a CPNP filing company hold the PIF but refuse authority contacts?

A third party can provide storage or filing support, but the legally identified RP must make the PIF readily accessible and comply with Article 5 authority-cooperation and incident duties. A passive-address arrangement is not equivalent.

Can we switch RP while old-labelled units remain in distribution?

Do not assume a seamless switch. Review stock, label identity, accepted appointment, PIF access, CPNP updates and responsibility for complaints before determining whether relabelling, other measures or a hold are needed.